LONKIRLO
Pharmaceutical preparations for the treatment of cancer, immunoproliferative disorders, inflammatory disorders and autoimmune disorders, hematological malignancies, lymphomas, T-cell lymphomas, cutaneous T cell lymphomas, Sezary Syndrome and Mycosis fungoides.
Registered · April 12, 2023 · 79373552 ·